XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Stock-based compensation expense is included on the Condensed Consolidated Statements of Income and Comprehensive Income based upon the job function of the employees receiving the grants as follows (in millions):
Three Months Ended
March 31,
 20232022
Lease and Well$12 $13 
Gathering and Processing Costs1 1 
Exploration Costs5 5 
General and Administrative16 16 
Total$34 $35 
Schedule of Weighted Average Fair Values and Valuation Assumptions Weighted average fair values and valuation assumptions used to value stock options and SARs granted during the three-month period ended March 31, 2022 and ESPP grants during the three-month periods ended March 31, 2023 and 2022 are as follows:
 Stock Options/SARsESPP
Three Months Ended
March 31,		Three Months Ended
March 31,
 202220232022
Weighted Average Fair Value of Grants$28.30 $32.31 $23.07 
Expected Volatility42.20 %42.97 %39.72 %
Risk-Free Interest Rate0.89 %4.66 %0.22 %
Dividend Yield3.28 %2.47 %3.32 %
Expected Life5.3 years0.5 years0.5 years
Schedule of Stock Options and SARs Transactions
The following table sets forth stock option and SAR transactions for the three-month periods ended March 31, 2023 and 2022 (stock options and SARs in thousands):
Three Months Ended
March 31, 2023		Three Months Ended
March 31, 2022
Number of
Stock
Options/SARs		Weighted
Average
Exercise
Price		Number of
Stock
Options/SARs		Weighted
Average
Exercise
Price
Outstanding at January 14,225 $77.49 9,969 $84.37 
Granted— — 2 97.64 
Exercised (1)
(175)77.08 (2,324)84.63 
Forfeited(31)79.83 (81)85.86 
Outstanding at March 31 (2)
4,019 $77.49 7,566 $84.28 
Vested or Expected to Vest (3)
3,875 $77.86 7,256 $85.05 
Exercisable at March 31 (4)
2,294 $84.89 3,886 $101.26 
(1)The total intrinsic value of stock options/SARs exercised during the three months ended March 31, 2023 and 2022 was $8 million and $62 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the exercise price of the stock options/SARs.
(2)The total intrinsic value of stock options/SARs outstanding at March 31, 2023 and 2022 was $155 million and $277 million, respectively. At March 31, 2023 and 2022, the weighted average remaining contractual life was 3.9 years and 4.3 years, respectively.
(3)The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2023 and 2022 was $149 million and $260 million, respectively. At March 31, 2023 and 2022, the weighted average remaining contractual life was 3.8 years and 4.3 years, respectively.
(4)The total intrinsic value of stock options/SARs exercisable at March 31, 2023 and 2022 was $74 million and $82 million, respectively. At both March 31, 2023 and 2022, the weighted average remaining contractual life was 2.9 years.
Schedule of Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth restricted stock and restricted stock unit transactions for the three-month periods ended March 31, 2023 and 2022 (shares and units in thousands):
Three Months Ended
March 31, 2023		Three Months Ended
March 31, 2022
Number of
Shares and
Units		Weighted
Average
Grant Date
Fair Value		Number of
Shares and
Units		Weighted
Average
Grant Date
Fair Value
Outstanding at January 14,113 $80.77 4,680 $69.37 
Granted36 122.34 14 110.66 
Released (1)
(38)55.23 (699)93.37 
Forfeited(42)84.23 (51)66.77 
Outstanding at March 31 (2)
4,069 $81.33 3,944 $65.30 
(1)The total intrinsic value of restricted stock and restricted stock units released during the three months ended March 31, 2023 and 2022 was $4 million and $81 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
(2)The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2023 and 2022 was $466 million and $470 million, respectively.
Schedule of Performance Award Transactions
The following table sets forth the Performance Unit transactions for the three-month periods ended March 31, 2023 and 2022 (units in thousands):
Three Months Ended
March 31, 2023		Three Months Ended
March 31, 2022
Number of
Units		Weighted
Average
Grant Date Fair Value		Number of
Units		Weighted
Average
Grant Date Fair Value
Outstanding at January 1688 $83.82 679 $84.97 
Granted— — — — 
Released (1)
(86)79.98 (57)136.74 
Forfeited for Performance Multiple (2)
(86)79.98 (56)136.74 
Outstanding at March 31 (3)
516 (4)$85.10 566 $74.60 
(1)The total intrinsic value of Performance Units released was $10 million and $7 million for the three months ended March 31, 2023 and 2022, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the Performance Units are released.
(2)Upon completion of the Performance Period for the Performance Units granted in 2019 and 2018, a performance multiple of 50% was applied to each of the grants resulting in a forfeiture of Performance Units in both February 2023 and February 2022.
(3)The total intrinsic value of Performance Units outstanding at March 31, 2023 and 2022 was approximately $59 million and $67 million, respectively.
(4)Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of zero and a maximum of 1,031 Performance Units could be outstanding.